Fasting glucose 100 mg/dL — the borderline-impaired-fasting-glucose threshold
A fasting plasma glucose of 100 mg/dL (5.6 mmol/L) sits exactly at the ADA threshold for 'impaired fasting glucose' (IFG) — the lower bound of formal prediabetes by glucose criteria. The WHO threshold is slightly higher (≥110 mg/dL / 6.1 mmol/L), so the same number can read 'borderline normal' in UK / EU contexts. Either way, fasting glucose at 100 indicates the basal glucose set-point has drifted upward, typically reflecting hepatic insulin resistance (the liver is producing too much glucose overnight) and is a reliable early signal that the metabolic-syndrome trajectory has begun. HbA1c often follows by 6-18 months if uncorrected.
Reference ranges
| Optimal | < 90 mg/dL (< 5.0 mmol/L) |
| Normal | < 100 mg/dL (< 5.6 mmol/L) |
| Impaired fasting glucose (ADA) | 100 – 125 mg/dL (5.6 – 6.9 mmol/L) |
| WHO normal upper bound | < 110 mg/dL (< 6.1 mmol/L) |
| Diabetes | ≥ 126 mg/dL (≥ 7.0 mmol/L) |
What this marker measures
Fasting plasma glucose reflects the equilibrium between hepatic glucose output and peripheral glucose uptake during the overnight fast. Healthy fasting glucose requires both: a liver that doesn't over-produce glucose (suppressed by insulin), and peripheral tissues (muscle, adipose) that maintain insulin sensitivity. As insulin resistance develops, the liver becomes the first tissue to lose insulin sensitivity in many cases, so hepatic glucose output rises overnight even at fasting insulin levels that previously suppressed it — and fasting glucose drifts up.
Why might it be elevated?
- ·Hepatic insulin resistance (most common cause of mild elevation)
- ·Visceral adiposity / hepatic steatosis
- ·Late dinner / nighttime eating (delayed glucose clearance into morning)
- ·Sleep deprivation (elevates AM cortisol → hepatic glucose output)
- ·Dawn phenomenon (counter-regulatory hormone rise pre-waking)
- ·Recent strenuous exercise the day before (transient stress hyperglycaemia)
- ·Type 2 diabetes (sustained > 126 mg/dL)
Why might it be low?
- ·Healthy insulin-sensitive baseline
- ·Recent caloric restriction or fasting
- ·Athletic training, particularly endurance
- ·Late-stage type 2 diabetes (rare — beta-cell exhaustion)
- ·Reactive hypoglycaemia (post-prandial only)
FAQ
Is one reading of 100 enough to be concerned?+
Not on its own. Single fasting glucose readings have ~5-10% intra-individual variability — a true 92 can read as 102 on a noisy day. The research-context next step is two more morning fasting reads 1-2 weeks apart, plus HbA1c, fasting insulin, and HOMA-IR. The combination tells you whether 100 is a noisy stable-baseline or the start of a trajectory.
Will lifestyle reverse it?+
Typically yes, faster than HbA1c. Resistance training, dietary improvement (lower refined-carb intake, late-meal restriction), sleep consolidation, and modest weight loss can drop fasting glucose 5-15 mg/dL within 4-8 weeks. The DPP and similar trials show ~58% reduction in T2D incidence with structured lifestyle change.
What about a CGM?+
Continuous glucose monitors (Levels, Veri, Stelo) provide much more information than a single fasting read — they capture postprandial spikes, time-in-range, glucose variability. Two weeks of CGM data is more clinically useful than four fasting readings. Recommended in research-context for anyone with borderline fasting glucose who wants to understand what's actually happening through the day.
This page describes biomarker research and reference ranges for self-tracking and research-context discussion only. It is not medical advice, not a diagnosis, and not a substitute for a qualified physician. Take any concerns about your health to a clinician.
Have your own panel? Read it next to the standard reference ranges with our free analyse tool.
Analyse my blood work →- BiomarkerHOMA-IR 2.5
HOMA-IR is a calculated index from fasting glucose × fasting insulin. A HOMA-IR of 2.5 sits at the threshold most metabolic research uses for early insulin resistance, often years before HbA1c shifts.
- BiomarkerHbA1c 5.7%
HbA1c at 5.7% is the formal threshold the ADA uses to define prediabetes — meaning your average blood glucose has been elevated over the past 2–3 months. What the number means and the research literature on intervention.
- BiomarkerFasting insulin 12
Fasting insulin of 12 µIU/mL is above the optimal threshold most metabolic research uses (~8). What it indicates, why doctors miss it, and the research literature on early insulin resistance.
- ResearchRetatrutide 40 mg pen
Retatrutide is a triple agonist at the GLP-1, GIP, and glucagon receptors. The 40 mg pen is the highest-dose presentation in the Omega Grade catalogue
- ResearchCagrilintide 10 mg
Cagrilintide is a long-acting amylin analogue most widely investigated in combination with semaglutide under the CagriSema programme. Commonly stacked
- ResearchRetatrutide 30 mg kit
Retatrutide 30 mg lyophilised vial kit — the mid-dose research presentation. Includes bacteriostatic water, syringes, and swabs.